UNREGISTERED SALES OF EQU ITY SECURITIES AND USE OF PROCEEDS
−Removed: Avitide Acquisition
−Removed: Pursuant to the Merger Agreement described in Note 3, "Acquisitions," to the consolidated financial statements, on September 20, 2021, the Company issued 271,096 unregistered shares of the Company's common stock, totaling $77.6 million, as part of the consideration for the Avitide Acquisition.
−Removed: The issuance is not registered under the Securities Act of 1933, as amended, in reliance upon the exemption from registration provided by Rule 506(b) of Regulation D.
DEFAULTS UPON SEN IOR SECURITIES
6 unchanged sentences
Third Amended and Restated Bylaws (filed as Exhibit 3.1 to Repligen Corporation’s Current Report on Form 8-K filed on January 28, 2021 and incorporated herein by reference).
+Added: Second Supplemental Indenture, dated as of March 4, 2022, by and between Repligen Corporation and Wilmington Trust, National Association, as trustee (filed as Exhibit 4.1 to Repligen Corporation's Current Report on Form 8-K filed on March 8, 2022 and incorporated herein by reference).
Rule 13a-14(a)/15d-14(a) Certification.
14 unchanged sentences
REPLIGEN CORPORATION
−Removed: October 28, 2021
+Added: April 27, 2022
/ S / T ONY J.
2 unchanged sentences
Repligen Corporation
−Removed: October 28, 2021
+Added: April 27, 2022
/ S / J ON S NODGRES
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.